These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 582429)
61. Chromosome Changes Caused by 6-Azauridine During Treatment of Acute Myeloblastic Leukaemia. Elves MW; Buttoo AS; Israels MC; Wilkison JF Br Med J; 1963 Jan; 1(5324):156-9. PubMed ID: 20789607 [No Abstract] [Full Text] [Related]
62. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776 [TBL] [Abstract][Full Text] [Related]
63. 6-azauridine triacetate induced hyper beta-alaninemia and its decrease by administration of pyridoxine. Slavik M; Blanc O; Smith KJ; Slavik J J Nutr Sci Vitaminol (Tokyo); 1983 Oct; 29(5):631-5. PubMed ID: 6198500 [TBL] [Abstract][Full Text] [Related]
64. Identification of 6-azauridine triphosphate in L1210 cells and its possible relevance to cytotoxicity. Wotring LL; Townsend LB Cancer Res; 1989 Jan; 49(2):289-94. PubMed ID: 2463073 [TBL] [Abstract][Full Text] [Related]
65. Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetate. Catalanotto FA; Slavik M; Danilson D; Keiser HR; Henkin RI Pharmacol Ther Dent; 1975; 2(1):25-32. PubMed ID: 1054856 [TBL] [Abstract][Full Text] [Related]
66. Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine. Slavik M; Smith KJ; Blanc O Biochem Pharmacol; 1982 Dec; 31(24):4089-92. PubMed ID: 6186258 [No Abstract] [Full Text] [Related]
67. Proceedings of the Workshop on Amino Acid Imbalance in the Treatment of Cancer. Introduction: possibilities for biochemically rational chemotherapy for some malignancies with depleting enzymes and antimetabolites of specific amino acids. Hanka LJ Cancer Treat Rep; 1979 Jun; 63(6):1009-11. PubMed ID: 380799 [TBL] [Abstract][Full Text] [Related]
68. [Cachexia in cancer: disturbances in the protein and aminoacid metabolism]. de Blaauw I; Deutz NE; von Meyenfeldt MF Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1408-13. PubMed ID: 10422554 [TBL] [Abstract][Full Text] [Related]
70. [Clinical significance of amino acid transformations as affected by pyridoxal phosphate enzymes]. Braunshteĭn AE Vestn Akad Med Nauk SSSR; 1982; (9):3-9. PubMed ID: 6755949 [No Abstract] [Full Text] [Related]
71. Neutral amino acid transport at the human blood-brain barrier. Pardridge WM; Choi TB Fed Proc; 1986 Jun; 45(7):2073-8. PubMed ID: 3519291 [TBL] [Abstract][Full Text] [Related]
72. Targeting amino acid metabolism for cancer therapy. Lukey MJ; Katt WP; Cerione RA Drug Discov Today; 2017 May; 22(5):796-804. PubMed ID: 27988359 [TBL] [Abstract][Full Text] [Related]
73. Changes in amino acid metabolism caused by 6-azauridine triacetate: relevance to cancer treatment. Slavik M Cancer Treat Rep; 1979 Jun; 63(6):1041-4. PubMed ID: 582429 [TBL] [Abstract][Full Text] [Related]